United Therapeutics CFO Disposes $5.75M in Stock as Options Are Exercised
United Therapeutics' CFO and treasurer, Edgemond James, sold 8,559 shares on April 13, 2026, under a pre-established Rule 10b5-1 plan, generating roughly $5.75 million. On the same day he exercised options for 10,000 shares at $135.42. The company's shares trade near a 52-week high following substantial year-over-year gains, while analysts and regu…